BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 7844451)

  • 1. [Treatment of leiomyomas with luteinizing hormone-releasing hormone agonist].
    Nakamura Y; Yoshimura Y; Yamada H; Maruyama K; Nanno T; Ubukata Y; Ando M; Takahashi K; Suzuki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Dec; 42(12):1620-6. PubMed ID: 2126024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma.
    Higashijima T; Kataoka A; Nishida T; Yakushiji M
    Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):169-73. PubMed ID: 8886702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
    Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
    Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of Doppler ultrasound in predicting the effect of gonadotropin-releasing hormone agonist (GnRHa) on myoma uteri].
    Yoshioka N
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Nov; 47(11):1255-60. PubMed ID: 8543851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of perimenopausal women with uterine myoma: successful use of a depot GnRH agonist leading to a natural menopause.
    Imai A; Sugiyama M; Furui T; Tamaya T
    J Obstet Gynaecol; 2003 Sep; 23(5):518-20. PubMed ID: 12963511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical usefulness of GnRH agonist therapy for premenopausal women with uterine leiomyoma].
    Kurose T; Hando T; Shiota A
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jan; 47(1):35-41. PubMed ID: 7844451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal therapy before surgical treatment for uterine leiomyomas.
    Moghissi KS
    Surg Gynecol Obstet; 1991 Jun; 172(6):497-502. PubMed ID: 1827931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
    Lethaby AE; Vollenhoven BJ
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GnRH analogues in the treatment of uterine fibroids.
    Golan A
    Hum Reprod; 1996 Nov; 11 Suppl 3():33-41. PubMed ID: 9147100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A benefit-risk assessment of medical treatment for uterine leiomyomas.
    De Leo V; Morgante G; La Marca A; Musacchio MC; Sorace M; Cavicchioli C; Petraglia F
    Drug Saf; 2002; 25(11):759-79. PubMed ID: 12222988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of patients with uterine myoma and its effectiveness].
    Vasil'chenko NP; Firichenko VI
    Akush Ginekol (Mosk); 1990 Feb; (2):7-10. PubMed ID: 2140246
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibroids: overview of current and future treatment options.
    Benagiano G; Morini A; Primiero FM
    Br J Obstet Gynaecol; 1992 Feb; 99 Suppl 7():18-22. PubMed ID: 1554684
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.